Search Results - "Colhoun HM"

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Authors: Colhoun HM Betteridge DJ Durrington PN et al.

Source: Lancet. 8/21/2004, Vol. 364 Issue 9435, p685-696. 12p.

Problems of reporting genetic associations with complex outcomes.

Authors: Colhoun HM McKeigue PM Smith GD et al.

Source: Lancet. 3/8/2003, Vol. 361 Issue 9360, p865-872. 8p.

Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.

Authors: Colhoun HM Betteridge DJ Durrington P et al.

Source: Diabetes. Sep2011, Vol. 60 Issue 9, p2379-2385. 7p.

Statins for patients with type 2 diabetes.

Authors: Pimpinella G Malgarini RB Martini N et al.

Source: Lancet. 11/27/2004, Vol. 364 Issue 9449, p1933-1934. 2p.

Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland.

Authors: McKeigue, PM Porter, D Hollick, RJ et al.

Source: Scandinavian Journal of Rheumatology. Jul2023, Vol. 52 Issue 4, p412-417. 6p.

The big picture on obesity and insulin resistance.

Authors: Colhoun HM Colhoun, Helen M

Source: Journal of the American College of Cardiology (JACC). Sep2002, Vol. 40 Issue 5, p944-945. 2p.

Effect of socioeconomic status on mortality among people with type 2 diabetes: a study from the Scottish Diabetes Research Network Epidemiology Group.

Authors: Walker JJ Livingstone SJ Colhoun HM et al.

Source: Diabetes Care. May2011, Vol. 34 Issue 5, p1127-1132. 6p.

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.

Authors: Boekholdt SM Arsenault BJ Mora S et al.

Source: JAMA: Journal of the American Medical Association. 3/28/2012, Vol. 307 Issue 12, p1302-1309. 8p.

Achieved levels of HbA1c and likelihood of hospital admission in people with type 1 diabetes in the Scottish population: a study from the Scottish Diabetes Research Network Epidemiology Group.

Authors: Govan L Wu O Briggs A et al.

Source: Diabetes Care. Sep2011, Vol. 34 Issue 9, p1992-1997. 6p.

Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS)

Authors: Neil HAW DeMicco DA Luo D et al.

Source: Diabetes Care. Nov2006, Vol. 29 Issue 11, p2378-2384. 7p.

URL: 23086880

Mortality in people with Type 2 diabetes in the UK.

Authors: Mulnier HE Seaman HE Raleigh VS et al.

Source: Diabetic Medicine. May2006, Vol. 23 Issue 5, p516-521. 6p.

URL: 20535235

High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database.

Authors: Soedamah-Muthu SS Fuller JH Mulnier HE et al.

Source: Diabetes Care. Apr2006, Vol. 29 Issue 4, p798-804. 7p.

URL: 20443244

Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study.

Authors: Livingstone SJ Looker HC Hothersall EJ et al.

Source: PLoS Medicine. Sep2012, Vol. 9 Issue 9, pe1001321-e1001321. 1p.

Long-term Effect of C-Peptide Level on Clinical Outcomes in the Scottish Type 1 Bioresource Cohort.

Authors: Mellor JC Blackbourn LAK McGurnaghan SJ et al.

Source: Diabetes care [Diabetes Care] 2026 Aug 01; Vol. 49 (8), pp. 1348-1356.

Publication Type: Journal Article

Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE

Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial.

Authors: Beernink JM Heerspink HJL Birkenfeld AL et al.

Corporate Authors: Beernink JM Heerspink HJL Birkenfeld AL et al.

Source: Diabetes care [Diabetes Care] 2026 Aug 01; Vol. 49 (8), pp. 1434-1441.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE

The Impact of Non-AKI eGFR Variability on CKD Progression in Individuals With Type 2 Diabetes and Preserved Kidney Function.

Authors: Hapca S Yang Q Li S et al.

Source: Kidney international reports [Kidney Int Rep] 2026 Jun 18; Vol. 11 (9), pp. 106667. Date of Electronic Publication: 2026 Jun 18 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101684752 Publication Model: eCollection Cited Medium: Internet ISSN: 2468-0249 (Electronic) Linking ISSN: 24680249 NLM ISO Abbreviation: Kidney Int Rep Subsets: PubMed not MEDLINE

Genome-Wide Aggregated Trans Effects Analysis for Circulating Proteins Indicates a Key Role of Immune Checkpoints in Type 1 Diabetes.

Authors: Zhou X Iakovliev A McGurnaghan S et al.

Source: Diabetes [Diabetes] 2025 Oct 01; Vol. 74 (10), pp. 1873-1884.

Publication Type: Journal Article

Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE

Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial.

Authors: Meyhöfer SM Cariou B Cercato C et al.

Corporate Authors: Meyhöfer SM Cariou B Cercato C et al.

Source: Nature medicine [Nat Med] 2026 May; Vol. 32 (5), pp. 1686-1693. Date of Electronic Publication: 2026 Apr 02.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Finerenone in Type 1 Diabetes and Chronic Kidney Disease.

Authors: Heerspink HJL Birkenfeld AL Cherney DZI et al.

Corporate Authors: Heerspink HJL Birkenfeld AL Cherney DZI et al.

Source: The New England journal of medicine [N Engl J Med] 2026 Mar 05; Vol. 394 (10), pp. 947-957.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors: Furth SL Colhoun HM Kanbay M et al.

Corporate Authors: Furth SL Colhoun HM Kanbay M et al.

Source: Kidney international [Kidney Int] 2026 Mar; Vol. 109 (3), pp. 442-464. Date of Electronic Publication: 2025 Oct 09.

Publication Type: Journal Article; Practice Guideline

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0323470 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1755 (Electronic) Linking ISSN: 00852538 NLM ISO Abbreviation: Kidney Int Subsets: MEDLINE